Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-019750
Filing Date
2025-10-27
Accepted
2025-10-27 16:30:06
Documents
3
Period of Report
2025-10-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 314969
2 GRAPHIC proxy_001.jpg GRAPHIC 408990
3 GRAPHIC proxy_002.jpg GRAPHIC 328204
  Complete submission text file 0001493152-25-019750.txt   1331684
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38286 | Film No.: 251420228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)